Johnie Rose

Johnie Rose

Auto-generated profile, based on publicly available information

Johnie Rose

Department of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, OH

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2015 in CA: A Cancer Journal for Clinicians
Verified
Journal Article
Open access
PDF file
KEKhaled El‐Shami
Khaled El‐Shami
KOKevin C. Oeffinger
Kevin C. Oeffinger
NENicole L. Erb
Nicole L. Erb
AWAnne Willis
Anne Willis
JBJennifer K. Bretsch
Jennifer K. Bretsch
RCRebecca L. Cowens‐Alvarado
Rebecca L. Cowens‐Alvarado
Answer questions and earn CME/CNE Colorectal cancer (CRC) is the third most common cancer and third leading cause of cancer death in both men and women and second leading cause of cancer death when men and women are combined in the United States (US). Almost two‐thirds of CRC survivors are living 5 years after diagnosis. Considering the recent decline in both incidence and mortality, the prevalence of CRC survivors is likely to increase dramatically over the coming decades with the increase in rates of CRC screening, further advances in early detection and treatment and the aging and growth of the US population. Survivors are at risk for a CRC recurrence, a new primary CRC, other cancers, as well as both short‐term and long‐term adverse effects of the CRC and the modalities used to treat it. CRC survivors may also have psychological, reproductive, genetic, social, and employment concerns after treatment. Communication and coordination of care between the treating oncologist and the primary care clinician is critical to effectively and efficiently manage the long‐term care of CRC survivors. The guidelines in this article are intended to assist primary care clinicians in delivering risk‐based health care for CRC survivors who have completed active therapy. CA Cancer J Clin 2015;65:427–455 . © 2015 American Cancer Society.

1 October 2015 in Cancer Epidemiology
Verified
Journal Article
Open access
KAK.M. Augestad
K.M. Augestad
PBP.M. Bakaki
P.M. Bakaki
JRJ. Rose
J. Rose
BCB.P. Crawshaw
B.P. Crawshaw
RLR.O. Lindsetmo
R.O. Lindsetmo
CDC.P. Delaney
C.P. Delaney
The most common sites of colorectal cancer (CRC) recurrence are the local tissues, liver or lungs. The objective was to identify risk factors associated with the primary CRC tumor and cancer recurrence in these anatomical sites. Retrospective, longitudinal analyses of data on CRC survivors. Multivariable Cox regression analysis was performed to examine the association between possible cofounders with recurrence to various anatomical sites. Data for 10,398CRC survivors (tumor location right colon=3870, left colon=2898, high rectum=2569, low rectum=1061) were analyzed; follow up time was up to five years. Mean age at curative surgery was 71.5 (SD 11.8) years, 20.2% received radio-chemotherapy, stage T3 (64.4%) and N0 (65.1%) were most common. Overall 1632 (15.7%) had cancer recurrence (Isolated liver n=412, 3,8%; isolated lung n=252, 2,4%; isolated local n=223, 2.1%). Risk factors associated with recurrent CRC were identified, i.e. isolated liver metastases (male: Adjusted Hazard Ratio (AHR) 1,45; colon left: AHR 1,63; N2 disease: AHR 3,35; T2 disease: AHR 2,82), isolated lung metastases (colon left: AHR 1,53; rectum high: AHR 2,48; rectum low: AHR 2,65; N2 disease 3,76), and local recurrence (glands examined<12: AHR 1,51; CRM <3mm: AHR 1,60; rectum high: AHR 2,15; N2 disease: AHR 2,58) (all p values <0001). Our study finds that the site of the primary CRC tumor is associated with location of subsequent metastasis. Left sided colon cancers have increased risk of metastatic spread to the liver, whereas rectal cancers have increased risk of local recurrence and metastatic spread to the lungs. These results, in combination with other risk factors for CRC recurrence, should be taken into consideration when designing risk adapted post-treatment CRC surveillance programs.

25 September 2009 in BMJ
Verified
Journal Article
Open access
PDF file
JRJohnie Rose
Johnie Rose
RHRachael L Hawthorn
Rachael L Hawthorn
BWBrook Watts
Brook Watts
MSMendel E Singer
Mendel E Singer
Objectives To examine the public health impact of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in a birth cohort in India, and to estimate the cost effectiveness and affordability of such a programme. Design Decision analytical Markov model encompassing all direct medical costs. Infection risk and severity depended on age, number of previous infections, and vaccination history; probabilities of use of inpatient and outpatient health services depended on symptom severity. Data sources Published clinical, epidemiological, and economic data. When possible, parameter estimates were based on data specific for India. Population Simulated Indian birth cohort followed for five years. Main outcome measures Decrease in rotavirus gastroenteritis episodes (non-severe and severe), deaths, outpatient visits, and admission to hospital; incremental cost effectiveness ratio of vaccination expressed as net cost in 2007 rupees per life year saved. Results In the base case, vaccination prevented 28 943 (29.7%) symptomatic episodes, 6981 (38.2%) severe episodes, 164 deaths (41.0%), 7178 (33.3%) outpatient visits, and 812 (34.3%) admissions to hospital per 100 000 children. Vaccination cost 8023 rupees (about £100, €113, $165) per life year saved, less than India’s per capita gross domestic product, a common criterion for cost effectiveness. The net programme cost would be equivalent to 11.6% of the 2006-7 budget of the Indian Department of Health and Family Welfare. Model results were most sensitive to variations in access to outpatient care for those with severe symptoms. If this parameter was increased to its upper limit, the incremental cost effectiveness ratio for vaccination still fell between one and three times the per capita gross domestic product, meeting the World Health Organization’s criterion for “cost effective” interventions. Uncertainty analysis indicated a 94.7% probability that vaccination would be cost effective according to a criterion of one times per capita gross domestic product per life year saved, and a 97.8% probability that it would be cost effective according to a criterion of three times per capita gross domestic product. Conclusions Across a wide range of assumptions, mass RIX4414 vaccination in India would probably prevent substantial morbidity and mortality at a cost per life year saved below typical thresholds of cost effectiveness. The opportunity costs of such a programme in this or similar settings, however, should be weighed up carefully.

1 September 2015 in The Annals of Family Medicine
Verified
Journal Article
Open access
PDF file
LHLaura Homa
Laura Homa
JRJohnie Rose
Johnie Rose
PHPeter S. Hovmand
Peter S. Hovmand
SCSarah T. Cherng
Sarah T. Cherng
RRRick L. Riolo
Rick L. Riolo
CWChristine Williams
Christine Williams
PURPOSE The paradox of primary care is the observation that primary care is associated with apparently low levels of evidence-based care for individual diseases, but systems based on primary care have healthier populations, use fewer resources, and have less health inequality. The purpose of this article is to explore, from a complex systems perspective, mechanisms that might account for the effects of primary care beyond disease-specific care. METHODS In an 8-session, participatory group model-building process, patient, caregiver, and primary care clinician community stakeholders worked with academic investigators to develop and refine an agent-based computer simulation model to test hypotheses about mechanisms by which features of primary care could affect health and health equity. RESULTS In the resulting model, patients are at risk for acute illness, acute life-changing illness, chronic illness, and mental illness. Patients have changeable health behaviors and care-seeking tendencies that relate to their living in advantaged or disadvantaged neighborhoods. There are 2 types of care available to patients: primary and specialty. Primary care in the model is less effective than specialty care in treating single diseases, but it has the ability to treat multiple diseases at once. Primary care also can provide disease prevention visits, help patients improve their health behaviors, refer to specialty care, and develop relationships with patients that cause them to lower their threshold for seeking care. In a model run with primary care features turned off, primary care patients have poorer health. In a model run with all primary care features turned on, their conjoint effect leads to better population health for patients who seek primary care, with the primary care effect being particularly pronounced for patients who are disadvantaged and patients with multiple chronic conditions. Primary care leads to more total health care visits that are due to more disease prevention visits, but there are reduced illness visits among people in disadvantaged neighborhoods. Supplemental appendices provide a working version of the model and worksheets that allow readers to run their own experiments that vary model parameters. CONCLUSION This simulation model provides insights into possible mechanisms for the paradox of primary care and shows how participatory group model building can be used to evaluate hypotheses about the behavior of such complex systems as primary health care and population health.


22 October 2021 in Inverse Problems
Verified
Journal Article
Closed access
DCDaniela Calvetti
Daniela Calvetti
AHAlex Hoover
Alex Hoover
JRJ Rose
J Rose
ESE Somersalo
E Somersalo
In this article, we consider a dynamic model for the spread of epidemics, in particular of COVID-19, and the inverse problem of estimating sequentially the time evolution of the unknown state and the model parameters based on noisy observations of the new daily infections. A characteristic of COVID-19 is the significant proportion of secondary infections though contacts with asymptomatic or oligosymptomatic infectious individuals. Since most of these individuals are not accounted for in the number of new daily infections, the size of this cohort can be inferred only indirectly through the underlying model. The evolution model used to propagate the current state from one data instance to the next is a suitably modified SEIR compartment model, providing the expected value for the new daily infection count that is modeled as a Poisson distributed random variable. The estimation of the state and the model parameters is based on a Bayesian particle filtering algorithm. The sequential Bayesian framework naturally provides a quantification of the uncertainty in the estimates of the model parameters, basic reproduction number, and size of the cohorts. Of particular interest is the fact that the algorithm makes it possible to estimate the size of the asymptomatic cohort, a key component for understanding the COVID-19 dynamics, and for planning mitigation measures. Alternative versions of the classical basic reproduction number for estimating the speed of the propagation of the disease are also proposed. The viability of the algorithm is demonstrated through a set of computed examples with both simulated realistic data and actual real data from selected US counties. The numerical tests show that the algorithm reproduces a ratio of asymptomatic vs symptomatic cohort sizes remarkably close to what is currently suggested by the Center for Disease Control.